(BTI) British American Tobacco - NYSE
Sector: Consumer Defensive | Industry: Tobacco | Exchange: NYSE (USA) | Market Cap: 134.666m USD | Total Return: 29.2% in 12m
Avg Turnover: 237M
EPS Trend: -26.3%
Qual. Beats: 0
Rev. Trend: 97.1%
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
British American Tobacco p.l.c. (BTI) is a global consumer goods company specializing in the manufacture and distribution of tobacco and nicotine products. Its portfolio includes traditional combustible cigarettes, fine-cut tobacco, and New Category segments such as vapor, heated tobacco, and modern oral nicotine pouches. The company operates an extensive distribution network reaching retail outlets across six continents.
The tobacco industry is currently characterized by a structural shift as major players transition from legacy combustibles to reduced-risk alternatives to offset declining cigarette volumes in developed markets. BTI utilizes a multi-category business model, leveraging established global brands like Dunhill, Lucky Strike, and Vuse to maintain market share across different consumer price points and regulatory environments.
For a deeper look into the companys financial health and valuation metrics, consider exploring the data available on ValueRay. British American Tobacco remains headquartered in London and has maintained its operations since 1902.
- Accelerated transition to non-combustible products offsets declining traditional cigarette volumes
- FDA regulatory scrutiny of vapor and menthol products impacts US revenue
- High dividend yield and share buybacks drive total shareholder returns
- Significant debt reduction targets influence credit ratings and capital allocation
- Emerging market volume growth compensates for developed market regulatory pressures
| Net Income: 7.76b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -2.71 > 1.0 |
| NWC/Revenue: -7.18% < 20% (prev -17.20%; Δ 10.01% < -1%) |
| CFO/TA 0.05 > 3% & CFO 5.73b > Net Income 7.76b |
| Net Debt (31.8b) to EBITDA (12.6b): 2.52 < 3 |
| Current Ratio: 0.87 > 1.5 & < 3 |
| Outstanding Shares: last fiscal year (2.20b) vs prev -1.17% < -2% |
| Gross Margin: 83.50% > 18% (prev 82.85%; Δ 0.65% > 0.5%) |
| Asset Turnover: 22.45% > 50% (prev 21.76%; Δ 0.69% > 0%) |
| Interest Coverage Ratio: 5.59 > 6 (EBIT TTM 10.5b / Interest Expense TTM 1.88b) |
| A: -0.02 (Total Current Assets 12.7b - Total Current Liabilities 14.5b) / Total Assets 109b |
| B: 0.21 (Retained Earnings 22.9b / Total Assets 109b) |
| C: 0.09 (EBIT TTM 10.5b / Avg Total Assets 114b) |
| D: 0.78 (Book Value of Equity 47.9b / Total Liabilities 61.1b) |
| Altman-Z'' = 2.02 = BBB |
| DSRI: 1.35 (Receivables 3.80b/2.85b, Revenue 25.6b/25.9b) |
| GMI: 0.99 (GM 82.85% / 83.50%) |
| AQI: 1.00 (AQ_t 0.84 / AQ_t-1 0.84) |
| SGI: 0.99 (Revenue 25.6b / 25.9b) |
| TATA: 0.02 (NI 7.76b - CFO 5.73b) / TA 109b) |
| Beneish M = -2.75 (Cap -4..+1) = A |
As of June 18, 2026, the stock is trading at USD 59.49 with a total of 3,646,078 shares traded.
Over the past week, the price has changed by -2.67%,
over one month by -10.34%,
over three months by -0.32% and
over the past year by +29.21%.
British American Tobacco has received a consensus analysts rating of 3.40. Therefore, it is recommended to hold BTI.
- StrongBuy: 1
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 67.5 | 13.5% |
Market Cap GBP = 100b (135b USD * 0.7457 USD.GBP)
P/E Trailing = 13.3734
P/E Forward = 12.7877
P/S = 5.2598
P/B = 2.1034
P/EG = 1.6116
Revenue TTM = 25.6b GBP
EBIT TTM = 10.5b GBP
EBITDA TTM = 12.6b GBP
Long Term Debt = 31.3b GBP (from longTermDebt, last quarter)
Short Term Debt = 3.36b GBP (from shortTermDebt, last quarter)
Debt = 35.6b GBP (from shortLongTermDebtTotal, last quarter) + Leases 529.0m
Net Debt = 31.8b GBP (calculated: Debt 35.6b - CCE 3.84b)
Enterprise Value = 132b GBP (100b + Debt 35.6b - CCE 3.84b)
Interest Coverage Ratio = 5.59 (Ebit TTM 10.5b / Interest Expense TTM 1.88b)
EV/FCF = 22.82x (Enterprise Value 132b / FCF TTM 5.79b)
FCF Yield = 4.38% (FCF TTM 5.79b / Enterprise Value 132b)
FCF Margin = 22.61% (FCF TTM 5.79b / Revenue TTM 25.6b)
Net Margin = 30.32% (Net Income TTM 7.76b / Revenue TTM 25.6b)
Gross Margin = 83.50% ((Revenue TTM 25.6b - Cost of Revenue TTM 4.23b) / Revenue TTM)
Gross Margin QoQ = 83.42% (prev 83.59%)
Tobins Q-Ratio = 1.21 (Enterprise Value 132b / Total Assets 109b)
Interest Expense / Debt = 5.29% (Interest Expense 1.88b / Debt 35.6b)
Taxrate = 21.24% (2.09b / 9.86b)
NOPAT = 8.29b (EBIT 10.5b * (1 - 21.24%))
Current Ratio = 0.87 (Total Current Assets 12.7b / Total Current Liabilities 14.5b)
Debt / Equity = 0.74 (Debt 35.6b / totalStockholderEquity, last quarter 47.9b)
Debt / EBITDA = 2.52 (Net Debt 31.8b / EBITDA 12.6b)
Debt / FCF = 5.48 (Net Debt 31.8b / FCF TTM 5.79b)
Total Stockholder Equity = 49.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.80% (Net Income 7.76b / Total Assets 109b)
RoE = 15.64% (Net Income TTM 7.76b / Total Stockholder Equity 49.6b)
RoCE = 12.99% (EBIT 10.5b / Capital Employed (Equity 49.6b + L.T.Debt 31.3b))
RoIC = 8.56% (NOPAT 8.29b / Invested Capital 96.8b)
WACC = 5.04% (E(100b)/V(136b) * Re(5.35%) + D(35.6b)/V(136b) * Rd(5.29%) * (1-Tc(0.21)))
Discount Rate = 5.35% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -79.57 | Cagr: -1.35%
[DCF] Terminal Value 73.10% ; FCFF base≈7.28b ; Y1≈6.39b ; Y5≈5.16b
[DCF] Fair Price = 23.63 (EV 82.8b - Net Debt 31.8b = Equity 51.1b / Shares 2.16b; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -26.32 | EPS CAGR: -54.01% | SUE: 0.0 | # QB: 0
Revenue Correlation: 97.05 | Revenue CAGR: 34.37% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=4.86 | Chg30d=-0.78% | Revisions=+20% | GrowthEPS=+1.2% | GrowthRev=+2.5%
EPS next Year (2027-12-31): EPS=5.27 | Chg30d=-0.86% | Revisions=+20% | GrowthEPS=+8.5% | GrowthRev=+3.6%
[Analyst] Revisions Ratio: +20%